Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in: Journal of Neurology 12/2013

01-12-2013 | Original Communication

Longitudinal study of cognitive and psychiatric functions in spinocerebellar ataxia types 1 and 2

Authors: Roberto Fancellu, Dominga Paridi, Chiara Tomasello, Marta Panzeri, Anna Castaldo, Silvia Genitrini, Paola Soliveri, Floriano Girotti

Published in: Journal of Neurology | Issue 12/2013

Login to get access

Abstract

The role of the cerebellum in cognition, both in healthy subjects and in patients with cerebellar diseases, is debated. Neuropsychological studies in spinocerebellar ataxia type 1 (SCA1) and type 2 (SCA2) demonstrated impairments in executive functions, verbal memory, and visuospatial performances, but prospective evaluations are not available. Our aims were to assess progression of cognitive and psychiatric functions in patients with SCA1 and SCA2 in a longitudinal study. We evaluated at baseline 20 patients with SCA1, 22 patients with SCA2 and 17 matched controls. Two subgroups of patients (9 SCA1, 11 SCA2) were re-evaluated after 2 years. We tested cognitive functions (Mini Mental State Examination, digit span, Corsi span, verbal memory, attentional matrices, modified Wisconsin Card Sorting Test, Raven Progressive Matrices, Benton test, phonemic and semantic fluency), psychiatric status (Scales for Assessment of Negative and Positive Symptoms, Hamilton Depression and Anxiety Scales), neurological conditions (Scale for Assessment and Rating of Ataxia), and functional abilities (Unified Huntington Disease Rating Scale–part IV). At baseline, SCA1 and SCA2 patients had significant deficits compared to controls, mainly in executive functions (phonemic and semantic fluencies, attentional matrices); SCA2 showed further impairment in visuospatial and visuoperceptive tests (Raven matrices, Benton test, Corsi span). Both SCA groups had higher depression and negative symptoms, particularly apathy, compared to controls. After 2 years, motor and functional disability worsened, while only attentive performances deteriorated in SCA2. This longitudinal study showed dissociation in progression of motor disability and cognitive impairment, suggesting that in SCA1 and SCA2 motor and cognitive functions might be involved with different progression rates.
Appendix
Available only for authorised users
Literature
1.
Schmahmann JD (ed) (1997) The cerebellum and cognition. International review of neurobiology, vol 41. Academic Press, San Diego
2.
3.
4.
Timmann D, Drepper J, Frings M, Maschke M, Richter S, Gerwig M, Kolb FP (2010) The human cerebellum contributes to motor, emotional and cognitive associative learning. A review. Cortex 46:845–857PubMedCrossRef
5.
Tedesco AM, Chiricozzi FR, Clausi S, Lupo M, Molinari M, Leggio MG (2011) The cerebellar cognitive profile. Brain 134:3672–3686PubMedCrossRef
6.
Appollonio IM, Grafman J, Schwartz V, Massaquoi S, Hallett M (1993) Memory in patients with cerebellar degeneration. Neurology 43:1536–1544PubMedCrossRef
7.
Grafman J, Litvan I, Massaquoi S, Stewart M, Sirigu A, Hallett M (1992) Cognitive planning deficit in patients with cerebellar atrophy. Neurology 42:1493–1496PubMedCrossRef
8.
Tavano A, Grasso R, Gagliardi C, Triulzi F, Bresolin N, Fabbro F, Borgatti R (2007) Disorders of cognitive and affective development in cerebellar malformations. Brain 130:2646–2660PubMedCrossRef
9.
Kish SJ, el-Awar M, Stuss D, Nobrega J, Currier R, Aita JF, Schut L, Zoghbi HY, Freedman M (1994) Neuropsychological test performance in patients with dominantly inherited spinocerebellar ataxia: relationship to ataxia severity. Neurology 44:1738–1746PubMedCrossRef
10.
Trojano L, Chiacchio L, Grossi D, Pisacreta AI, Calabrese O, Castaldo I, De Michele G, Filla A (1998) Determinants of cognitive disorders in autosomal dominant cerebellar ataxia type 1. J Neurol Sci 157:162–167PubMedCrossRef
11.
Koziol LF, Budding DE, Chidekel D (2012) From movement to thought: executive function, embodied cognition, and the cerebellum. Cerebellum 11:505–525PubMedCrossRef
12.
Kawai Y, Suenaga M, Watanabe H, Sobue G (2009) Cognitive impairment in spinocerebellar degeneration. Eur Neurol 61:257–268PubMedCrossRef
13.
Leggio MG, Chiricozzi FR, Clausi S, Tedesco AM, Molinari M (2011) The neuropsychological profile of cerebellar damage: the sequencing hypothesis. Cortex 47:137–144PubMedCrossRef
14.
Sokolovsky N, Cook A, Hunt H, Giunti P, Cipolotti L (2010) A preliminary characterisation of cognition and social cognition in spinocerebellar ataxia types 2, 1, and 7. Behav Neurol 23:17–29PubMed
15.
Schmahmann JD (2010) The role of the cerebellum in cognition and emotion: personal reflections since 1982 on the dysmetria of thought hypothesis, and its historical evolution from theory to therapy. Neuropsychol Rev 20:236–260PubMedCrossRef
16.
17.
Dürr A (2010) Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol 9:885–894PubMedCrossRef
18.
Whaley NR, Fujioka S, Wszolek ZK (2011) Autosomal dominant cerebellar ataxia type I: a review of the phenotypic and genotypic characteristics. Orphanet J Rare Dis 6:33PubMedCrossRef
19.
20.
Brusco A, Gellera C, Cagnoli C, Saluto A, Castucci A, Michielotto C, Fetoni V, Mariotti C, Migone N, Di Donato S, Taroni F (2004) Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families. Arch Neurol 61:727–733PubMedCrossRef
21.
Bürk K, Globas C, Bösch S, Gräber S, Abele M, Brice A, Dichgans J, Daum I, Klockgether T (1999) Cognitive deficits in spinocerebellar ataxia 2. Brain 122:769–777PubMedCrossRef
22.
Bürk K, Bösch S, Globas C, Zühlke C, Daum I, Klockgether T, Dichgans J (2001) Executive dysfunction in spinocerebellar ataxia type 1. Eur Neurol 46:43–48PubMedCrossRef
23.
Bürk K, Globas C, Bösch S, Klockgether T, Zühlke C, Daum I, Dichgans J (2003) Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. J Neurol 250:207–211PubMedCrossRef
24.
Gambardella A, Annesi G, Bono F, Spadafora P, Valentino P, Pasqua AA, Mazzei R, Montesanti R, Conforti FL, Oliveri RL, Zappia M, Aguglia U, Quattrone A (1998) CAG repeat length and clinical features in three Italian families with spinocerebellar ataxia type 2 (SCA2): early impairment of Wisconsin card sorting test and saccade velocity. J Neurol 245:647–652PubMedCrossRef
25.
Orsi L, D’Agata F, Caroppo P, Franco A, Caglio MM, Avidano F, Manzone C, Mortara P (2011) Neuropsychological picture of 33 spinocerebellar ataxia cases. J Clin Exp Neuropsychol 33:315–325PubMedCrossRef
26.
Klinke I, Minnerop M, Schmitz-Hübsch T, Hendriks M, Klockgether T, Wüllner U, Helmstaedter C (2010) Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6. Cerebellum 9:433–442PubMedCrossRef
27.
Filla A, De Michele G, Campanella G, Perretti A, Santoro L, Serlenga L, Ragno M, Calabrese O, Castaldo I, De Joanna G, Cocozza S (1996) Autosomal dominant cerebellar ataxia type I. Clinical and molecular study in 36 Italian families including a comparison between SCA1 and SCA2 phenotypes. J Neurol Sci 142:140–147PubMedCrossRef
28.
Valis M, Masopust J, Bažant J, Ríhová Z, Kalnická D, Urban A, Zumrová A, Hort J (2011) Cognitive changes in spinocerebellar ataxia type 2. Neuro Endocrinol Lett 32:354–359PubMed
29.
D’Agata F, Caroppo P, Boghi A, Coriasco M, Caglio M, Baudino B, Sacco K, Cauda F, Geda E, Bergui M, Geminiani G, Bradac GB, Orsi L, Mortara P (2011) Linking coordinative and executive dysfunctions to atrophy in spinocerebellar ataxia 2 patients. Brain Struct Funct 216:275–288PubMedCrossRef
30.
Le Pira F, Zappalà G, Saponara R, Domina E, Restivo D, Reggio E, Nicoletti A, Giuffrida S (2002) Cognitive findings in spinocerebellar ataxia type 2: relationship to genetic and clinical variables. J Neurol Sci 201:53–57PubMedCrossRef
31.
Le Pira F, Giuffrida S, Maci T, Marturano L, Tarantello R, Zappalà G, Nicoletti A, Zappia M (2007) Dissociation between motor and cognitive impairments in SCA2: evidence from a follow-up study. J Neurol 254:1455–1456PubMedCrossRef
32.
Storey E, Forrest SM, Shaw JH, Mitchell P, Gardner RJ (1999) Spinocerebellar ataxia type 2: clinical features of a pedigree displaying prominent frontal-executive dysfunction. Arch Neurol 56:43–50PubMedCrossRef
33.
Schmitz-Hübsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, Giunti P, Globas C, Infante J, Kang JS, Kremer B, Mariotti C, Melegh B, Pandolfo M, Rakowicz M, Ribai P, Rola R, Schöls L, Szymanski S, van de Warrenburg BP, Dürr A, Klockgether T, Fancellu R (2006) Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66:1717–1720PubMedCrossRef
34.
Klockgether T, Lüdtke R, Kramer B, Abele M, Bürk K, Schöls L, Riess O, Laccone F, Boesch S, Lopes-Cendes I, Brice A, Inzelberg R, Zilber N, Dichgans J (1998) The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain 121:589–600PubMedCrossRef
35.
Huntington Study Group (1996) Unified Huntington’s Disease Rating Scale: reliability and consistency. Mov Disord 11:136–142CrossRef
36.
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef
37.
Measso G, Cavarzeran F, Zappalà G, Lebowitz BD, Crook TH, Pirozzolo FJ, Amaducci LA, Massari D, Grigoletto F (1993) The mini-mental state examination: normative study of an Italian random sample. Dev Neuropsychol 9:77–95CrossRef
38.
Orsini A, Grossi D, Capitani E, Laiacona M, Papagno C, Vallar G (1987) Verbal and spatial immediate memory span: normative data from 1355 adults and 112 children. Ital J Neurol Sci 8:539–548PubMedCrossRef
39.
Spinnler H, Tognoni G (1987) Standardizzazione e taratura italiana di test psicometrici. Ital J Neurol Sci 8(Suppl. 6):7–120
40.
Novelli G, Papagno C, Capitani E, Laiacona M, Cappa SF, Vallar G (1986) Tre test clinici di memoria verbale a lungo termine. Taratura su soggetti normali. Archivio di Psicologia Neurologia e Psichiatria 2:278–296
41.
Nelson HE (1976) A modified card sorting test sensitive to frontal lobe defects. Cortex 12:313–324PubMedCrossRef
42.
Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A (2004) Modified card sorting test: normative data. J Clin Exp Neuropsychol 26:246–250PubMedCrossRef
43.
Raven JC (1962) Coloured progressive Matrices Sets A, Ab, B. HK Lewis, London
44.
Basso A, Capitani E, Laiacona M (1987) Raven’s coloured progressive matrices: normative values on 305 adult normal controls. Funct Neurol 2:189–194PubMed
45.
Benton AL, Sivan AB, Des Hamsher K, Varney NR, Spreen O (1994) Contribution to neuropsychological assessment: a clinical manual, 2nd edn. Oxford University Press, New York
46.
Ferracuti S, Cannoni E, Sacco R, Hufty AM (2000, ristampa 2007) Contributi per un assessment neuropsicologico. Manuale clinico. Giunti Organizzazioni Speciali, Firenze
47.
48.
49.
50.
Andreasen NC (1990) Methods for assessing positive and negative symptoms. Mod Probl Pharmacopsychiatry 24:73–88PubMed
51.
Stoodley CJ, Schmahmann JD (2010) Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing. Cortex 46:831–844PubMedCrossRef
52.
Berent S, Giordani B, Gilman S, Trask CL, Little RJ, Johanns JR, Junck L, Kluin KJ, Heumann M, Koeppe RA (2002) Patterns of neuropsychological performance in multiple system atrophy compared to sporadic and hereditary olivopontocerebellar atrophy. Brain Cogn 50:194–206PubMedCrossRef
53.
54.
Jacobi H, Hauser TK, Giunti P, Globas C, Bauer P, Schmitz-Hübsch T, Baliko L, Filla A, Mariotti C, Rakowicz M, Charles P, Ribai P, Szymanski S, Infante J, van de Warrenburg BP, Dürr A, Timmann D, Boesch S, Fancellu R, Rola R, Depondt C, Schöls L, Zdzienicka E, Kang JS, Ratzka S, Kremer B, Stephenson DA, Melegh B, Pandolfo M, Tezenas du Montcel S, Borkert J, Schulz JB, Klockgether T (2012) Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings. Cerebellum 11:155–166PubMedCrossRef
55.
Brandt J, Leroi I, O’Hearn E, Rosenblatt A, Margolis RL (2004) Cognitive impairments in cerebellar degeneration: a comparison with Huntington’s disease. J Neuropsychiatry Clin Neurosci 16:176–184PubMedCrossRef
56.
Wolf U, Rapoport MJ, Schweizer TA (2009) Evaluating the affective component of the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci 21:245–253PubMedCrossRef
57.
Schmitz-Hübsch T, Coudert M, Giunti P, Globas C, Baliko L, Fancellu R, Mariotti C, Filla A, Rakowicz M, Charles P, Ribai P, Szymanski S, Infante J, van de Warrenburg BP, Dürr A, Timmann D, Boesch S, Rola R, Depondt C, Schöls L, Zdzienicka E, Kang JS, Ratzka S, Kremer B, Schulz JB, Klopstock T, Melegh B, du Montcel ST, Klockgether T (2010) Self-rated health status in spinocerebellar ataxia—results from a European multicenter study. Mov Disord 25:587–595PubMedCrossRef
58.
Schmitz-Hübsch T, Coudert M, Tezenas du Montcel S, Giunti P, Labrum R, Dürr A, Ribai P, Charles P, Linnemann C, Schöls L, Rakowicz M, Rola R, Zdzienicka E, Fancellu R, Mariotti C, Baliko L, Melegh B, Filla A, Salvatore E, van de Warrenburg BP, Szymanski S, Infante J, Timmann D, Boesch S, Depondt C, Kang JS, Schulz JB, Klopstock T, Lossnitzer N, Löwe B, Frick C, Rottländer D, Schlaepfer TE, Klockgether T (2011) Depression comorbidity in spinocerebellar ataxia. Mov Disord 26:870–876PubMedCrossRef
59.
Leroi I, O’Hearn E, Marsh L, Lyketsos CG, Rosenblatt A, Ross CA, Brandt J, Margolis RL (2002) Psychopathology in patients with degenerative cerebellar diseases: a comparison to Huntington’s disease. Am J Psychiatry 159:1306–1314PubMedCrossRef
60.
Liszewski CM, O’Hearn E, Leroi I, Gourley L, Ross CA, Margolis RL (2004) Cognitive impairment and psychiatric symptoms in 133 patients with diseases associated with cerebellar degeneration. J Neuropsychiatry Clin Neurosci 16:109–112PubMedCrossRef
61.
Krishnamoorthy A, Craufurd D (2011) Treatment of apathy in Huntington’s disease and other movement disorders. Curr Treat Options Neurol 13:508–519PubMedCrossRef
62.
Park KM, Kim JJ, Seok JH, Chun JW, Park HJ, Lee JD (2009) Anhedonia and ambivalence in schizophrenic patients with fronto-cerebellar metabolic abnormalities: a fluoro-d-glucose positron emission tomography study. Psychiatry Investig 6:72–77PubMedCrossRef
63.
Andreasen NC, Paradiso S, O’Leary DS (1998) “Cognitive dysmetria” as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry? Schizophr Bull 24:203–218PubMedCrossRef
64.
Jacobi H, Bauer P, Giunti P, Labrum R, Sweeney MG, Charles P, Dürr A, Marelli C, Globas C, Linnemann C, Schöls L, Rakowicz M, Rola R, Zdzienicka E, Schmitz-Hübsch T, Fancellu R, Mariotti C, Tomasello C, Baliko L, Melegh B, Filla A, Rinaldi C, van de Warrenburg BP, Verstappen CC, Szymanski S, Berciano J, Infante J, Timmann D, Boesch S, Hering S, Depondt C, Pandolfo M, Kang JS, Ratzka S, Schulz J, Tezenas du Montcel S, Klockgether T (2011) The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology 77:1035–1041PubMedCrossRef
Metadata
Title
Longitudinal study of cognitive and psychiatric functions in spinocerebellar ataxia types 1 and 2
Authors
Roberto Fancellu
Dominga Paridi
Chiara Tomasello
Marta Panzeri
Anna Castaldo
Silvia Genitrini
Paola Soliveri
Floriano Girotti
Publication date
01-12-2013
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 12/2013
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-013-7138-1

Other articles of this Issue 12/2013

Journal of Neurology 12/2013 Go to the issue

Original Communication

Levels of HVA, 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to Parkinson’s disease and controls

Original Communication

Serum anticardiolipin antibodies in patients with neuromyelitis optica spectrum disorder

Original Communication

Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort

Pioneers in Neurology

Norman Geschwind (1926–1984)

Letter to the Editors

Juvenile parkinsonism as an initial manifestation of gliomatosis cerebri

Original Communication

Intravenous amantadine on freezing of gait in Parkinson’s disease: a randomized controlled trial